Cargando…
Obesity and Risk of Recurrence in Patients With Breast Cancer Treated With Aromatase Inhibitors
IMPORTANCE: Clinical studies confirm that obesity is a risk factor for recurrence in postmenopausal women with hormone receptor–positive (HR+) breast cancer. Evidence suggests that women with obesity do not obtain similar protection from aromatase inhibitors as women with healthy weight. OBJECTIVE:...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Medical Association
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576219/ https://www.ncbi.nlm.nih.gov/pubmed/37831449 http://dx.doi.org/10.1001/jamanetworkopen.2023.37780 |